Peter de Keizer, Ph.D.

Managing Director, Founder at Cleara Biotech

Speaker

Peter L.J. de Keizer, PhD, is associate professor “Senescence in Cancer and Aging” at University Medical Center Utrecht, the Netherlands. In addition, he is the Founder and Managing Director of Cleara Biotech B.V., a company focused on identifying and eliminating subtypes of cellular senescence. He was the first to design compounds to eliminate senescent cells and showed this could restore tissue homeostasis in (fast) aging mice (Cell, 2017). Peter is a recurring guest in general media, including 50+ items on (inter)national television, newspapers, radio and blogs. Peter is a board member of the Dutch Society for Research on Aging (DuSRA).

Peter’s research is focused on the fact that what we call senescence, is actually a range of phenotypes. Through multiplex characterization, he aims to investigate their heterogeneity and deleterious effects on stemness and regeneration of neighboring cells. In parallel, he founded Cleara Biotech B.V. to generate and translate 4th generation FOXO4 peptides against “scarred” senescent cells, which are in preclinical development against scarred metastatic cancer.